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Abstract. The c-erbA proto-oncogenes ncode nuclear 
receptors for thyroid hormone (T3), a hormone inti- 
mately involved in mammalian brain maturation. To 
study thyroid hormone receptor (TR) action on neu- 
ronal cells in vitro, we expressed the chicken c-erbA/ 
TRot-1 as well as its oncogenic variant v-erbA in the 
adrenal medulla progenitor cell line PC12. In the ab- 
sence of T3, exogenous TRc~-I inhibits NGF-induced 
neuronal differentiation and represses neuron-specific 
gene expression. In contrast, TRo~-I allows normal 
differentiation and neuronal gene expression to occur 
in the presence of T3. Finally, TRc~-l-expressing cells 
become NGF-responsive for proliferation when T3 is 
absent, but NGF-dependent for survival in presence of 
T3. A similar differentiation i duction by NGF plus T3 
was observed in a central nervous ystem-derived neu- 
ronal cell line (E 18) expressing exogenous TRot-1. 
Together with the finding that TRo~-I constitutively 
blocked dexamethasone-induced differentiation of PC12 
cells into the chromaffin pathway, these results suggest 
that TRet-1 plays an important role in regulating com- 
mitment and maturation of neuronal progenitors. 
In contrast, the v-erbA oncogene, a mutated, onco- 
genic version of TRc~-I, partially but constitutively in- 
hibited NGF-induced neuronal differentiation of PC12 
cells and potentiated dexamethasone-induced chromaflin 
differentiation, giving rise to an aberrant "intedineage" 
cell phenotype. 
T iaYaoio hormone (3,5,3'-triiodo-L-thyronine, T3)t is 
an essential regulator of physiological and develop- 
mental processes in many cells and tissues. In partic- 
ular, T3 plays a crucial role in late embryonic and neonatal 
development of the brain (for reviews see Hamburg, 1969; 
Morreale de Escobar et al., 1983; Legrand, 1984; Dussault 
and Ruel, 1987). Deprivation of thyroid hormone during rat 
brain development causes diverse histological and cellular 
abnormalities such as changes in cell populations, decreases 
in axon densities, dendrite formation and myelin deposition, 
and alterations of cell migration, leading to severe impair- 
ment of brain maturation and function. These alterations are 
reversible by T3 replacement until a certain age and might 
reflect aberrant or even absent differentiation ofboth neurons 
and glial cells. In humans, permanent mental deficiency due 
to insufficient T3 levels can only be avoided if replacement 
therapy is started early after birth. In spite of the crucial im- 
portance of thyroid hormone for proper development ofthe 
central nervous ystem (CNS), very little is known about he 
molecular basis of thyroid hormone receptor action in neu- 
ronal ceils, most likely due to the complexity of the CNS and 
1. Abbreviations used in this paper: CNS, central nervous ystem; DEX, 
dexamethasone; RA, retionic acid; RAR, retionic acid receptor; TH, tyro- 
sine hydroxylase; TR, thyroid receptor; T3 triiodothyronine. 
the asynchronic patterns of development among their differ- 
ent parts and cell groups. Only recently, a few genes were 
found to be regulated at the pretranslational level by thyroid 
hormone in vivo (Mufioz et al., 1991). 
After identification of the c-erbA proto-oncogene as the 
thyroid hormone receptor (TR) a-1 (Sap et al., 1986; Wein- 
berger et al., 1986) and discovery of two erbA genes in 
higher organisms (or and /3) encoding a whole family of 
different receptor proteins, several groups detected erbA ex- 
pression in the brain. CNS neurons express the thyroid hor- 
mone receptor, and an increase in Trbinding sites corre- 
lates with the period of neuroblast proliferation in human 
fetuses (Bernal and Pekonen, 1984). TRot RNA has been de- 
tected very early (day 4) in the embryonal chicken brain, in- 
creasing progressively thereafter during the embryonai 
period (Forrest et al., 1990, 1991). TR/3 appears later in em- 
bryogenesis, becoming predominant in certain areas of both 
the CNS and the eye (Forrest et al., 1991). During rat brain 
maturation, both ot and/3 receptors are expressed in a dis- 
tinct fashion characterized by tight temporal and spatial 
regulation (Bradley et al., 1989; Strait et al., 1991; Mell- 
strtm et al., 1991). In situ hybridization studies indicate that 
TR mRNAs are present mainly in neurons from those brain 
areas known to be targets of thyroid hormone, such as the 
cerebral cortex, hippocampus, cerebellum, and basal gan- 
glia. In particular, cholinergic ells of the basal forebrain are 
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sensitive to thyroid hormones (Gould and Butcher, 1989). 
These cells also express maximum levels of the high affinity 
(gpl4(~ rk) NGF receptor (Holtzman et al., 1992) and thy- 
roid hormone and NGF were found to cooperate inthe devel- 
opment of specific cholinergic markers in basal ganglia 
(Patel et al., 1988) and other CNS areas (Clos and Legrand, 
1990). These findings trongly suggest a key role of thyroid 
hormone receptors in neural tissue formation and matura- 
tion, probably involving cooperation with neurotrophins. 
We have addressed this question by studying the effects of 
% on neuronal cells differentiating in culture. Unfortu- 
nately, appropriate neuronal cell lines from the CNS capable 
of in vitro differentiation in response to neurotrophic factors 
are missing and primary cells obtained from brain do not 
grow in culture for extended time periods, hampering long- 
term studies. We therefore mployed the PC12 cell line that 
has been extensively used as a model system for neuronal 
differentiation since its establishment from a rat pheochro- 
mocytoma (Greene and Tischler, 1976). PC12 cells show 
characteristics of common precursor cells for sympathetic 
adrenergic neurons and neurosecretory epithelioid chromaf- 
fin cells. NGF induces PC12 cells to differentiate along the 
neuronal pathway, whereas glucocorticoid hormones pro- 
mote their differentiation i to chromaffin cells (Greene and 
Tischler, 1982; Levi et al., 1988). Thus, PC12 differentia- 
tion in vitro at least partially mirrors differentiation of 
respective neural crest-derived progenitor ceils in the rat 
adrenal medulla in vivo (Doupe et al., 1985a,b; Anderson 
and Axel, 1986). 
Because of their origin from a tumor, it was not surprising 
that PC12 ceils behave aberrantly inseveral ways when com- 
pared to normal precursor cells in vivo. They continuously 
grow in the absence of neurotrophic factors, show an altered 
response to various exogenous stimuli and differentiate only 
partially into either neuronal or chromaffin cells. Also, they 
show no known response to thyroid hormone, a result also 
obtained in our own pilot experiments. This could be due to 
expression of low levels of c-erbA/TRot-1 together with high 
levels of c-erbA/TRot-2 RNA, which encodes a variant form 
of the receptor generated by differential splicing. TRot-2 is 
unable to bind hormone but efficiently blocks transcriptional 
activation by the active c-erbA/TRot-1 form (Koenig et al., 
1989; Lazar et al., 1989; Rentoumis et al., 1990). 
For these reasons, we decided to stably express an exoge- 
nous TRot-1 gene in PC12 cells using suitable retroviral vec- 
tors (Mufioz et al., 1990). The rationale behind this study 
was to restore TRot-1 expression i  a neuronal progenitor 
cell line that express only low levels of TRot-I, most likely 
as a consequence of the immortalization process, and then 
analyze neuronal differentiation in response to thyroid hor- 
mone and neurotrophic factors. We show in this paper that 
exogenous TRot-1 expressed at physiological levels regulates 
NGF-dependent differentiation a d gene expression of PC12 
cells in a T3 dependent fashion and constitutively blocks 
their entry into the chromaffin differentiation pathway. In ad- 
dition, ligand-activated TRot-1 renders PC12 cells dependent 
on NGF as a neurotrophic factor. In contrast o TRot-l, 
v-erbA, a mutated, oncogenic version of TRot-1 that seems 
to act as a constitutive r pressor of genes regulated by c-erbA/ 
TRot-1 (Danun et al., 1989; Sap et al., 1989; Disela et al., 
1991), constitutively inhibited both neuronal and chromaffin 
differentiation f PC12 cells. 
Materials and Methods 
Cells and Cell Cultures 
A clonal subline of rat PCI2 cells (referred to as 6c) was used throughout. 
This clone responded particularly well to differentiation induction by NGF 
in terms of neurite outgrowth on standard plastic dishes. 0Vrighton, C. W., 
and M. Busslinger, unpublished observations). PC12 6c cells were grown 
in DME supplemented with 10% horse serum, 5% FCS, and 1 mM gluta- 
mine (standard growth medium) (all from GIBCO, U.K.). Establishment 
and properties of the E 18 cell line derived by spontaneous immortalization 
from 17-d embryonic rat brain will be described elsewhere (Seliger, B., un- 
published observations). Cells were grown in Ham's F12 medium sup- 
plemented with 10% FCS. 
Retrovirus Vectors and Generation 
of erbA-overexpressing Cells 
The recombinant retroviruses encoding the chicken c-erbA/TRct-1 and 
v-erbA genes used to infect PC12 6c cells have been already described (Mu- 
fioz et ai., 1990). Both are derived from the Moloney murine leukemia virus 
and encode the neomycin-resistant gene providing resistance tothe antibi- 
otic G418. For infection, 5 x 105 cells were plated in 60-ram dishes and 
incubated overnight with fibroblast-grown virus plus 8/~g/ml polybrene 
(Sigma Chem. Co., St. Louis, MO). Medium was then changed and selec- 
tion with 800 #g/ml (3418 (GIBCO BRL, Gaithersburg, MD) started 48 h 
after infection (Mufioz et al., 1990). Six clones of resistant TR~l-infected 
cells could be expanded separately (cAI-cA6). cA4, the clone exhibiting the 
highest specific T3-specific binding was used in all experiments. In con- 
trast, no individual v-erbA-infected clones could be expanded. Therefore, 
a pool of G418 resistant, v-erbA-expressing clones was used. 
Infection of E 18 cells with TRot-1 was done exactly as described for 
PC12 6c. Ten TRot-l-expressing clones were obtained, one of which show- 
ing reproducible, high TRa-1 expression as determined by T3 binding (E 
18 cA9) was used in the experiments. 
Induction of Neural and Chroma~in Differentiation 
For induction of optimal neuronal differentiation, well suspended PC12 6c 
cells were seeded at 104 cells per cm 2 in standard growth medium. Murine 
7 S NGF (Sigma Chem. Co.) was added at a concentration f 50 ng/ml every 
2 d. Triiodothyronine (Sigma Chem. Co.) was added aily at a final concen- 
tration of 150 nM. Medium was changed partially or totally every 48 h. 
Chromaitin differentiation was induced by treatment with dexamethasone (5 
t~g/ml; Serva, Heidelberg) every 2 d or when the medium was changed. 
Embryonic CNS neuroblasts (E 18 cA9) were induced to differentiate by
seeding them in serum-free Dulbecco's plus Ham's F12 (1:1) medium sup- 
plemented with the additions of N2 differentiation medium (Bottenstein 
and Sato, 1979). NGF (50 ng/ml) was added every 2 d while T3 (150 nM) 
was added daily. 
pH]Thymidine Incorporation Assay 
Cells were seeded into 35-ram dishes in 2 nd standard growth medium at 
a density of 8 x 104 cells per dish and treated with NGF and/or 1"3 as de- 
scribed above. Cell monolayers were labeled for 3.5 h with 1 /~Ci [6-3H] 
thymidine (25 Ci/mmol: Amersham Intl., Buckinghamshire, U.K.), 
washed twice with PBS, precipitated with 10% trichloroacetic a id for 10 
min, air-dried, and dissolved in 400 #1 of 0.1% NaOH and I% SDS. Radio- 
activity in 200/zl was estimated in a/3 counter. 
Mitomycin-C Treatment 
Cells were treated for 2 h with mitomycin-C (Sigma Chem. Co.) at a final 
concentration f 20/~g/ml. In pilot experiments, his concentration inhibited 
thymidine incorporation to <1% of respective controls without producing 
toxic effects. Monolayers were then washed three times with PBS, incubated 
for 30 rain with fresh medium, washed again, and then trypsinized and 
reseeded for differentiation i duction. Except for different mitomycin-C 
concentrations, the same procedure was previously used to demonstrate that 
differentiation ccurs in absence of cell division in myoblasts (Falcone t 
al., 1984), macrophages (Beug et al., 1987), and erythroid cells (Beug et 
al., 1992). 
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Immunoprecipitation 
Detection of erbA protein (p46 c'erbA and p75SaS-v-e,~A) by [3SS]methionine 
labeling and immunoprecipitation analysis was done as described earlier 
(Goldberg et al., 1988; Glinenr et al., 1990) using an anti-v-erbA antibody 
generously donated by Dr. J. Ghysdael. 
Hormone Binding Assay 
T3-specific binding assays in vivo were performed as previously described 
(Sap et al., 1986; Mu5oz et al., 1990). Specific binding is defined as the 
ratio of iodinated T3 bound in absence and presence of a 1,000-fold molar 
excess unlabeled T3. 
Detection of Neuronal and Chromaffin Differentiation 
Antigens by Immunofluorescence 
Fixed and permeabilized cells were analyzed by indirect immunofluores- 
cence using monoclonal ntibodies to synaptophysin, tyrosine hydroxylase, 
glial fibrillary acidic protein (all from Boehringer Mannheim Corp., Ger- 
many), and N-CAM (Sigma Chem. Co.) according to standard procedures. 
Rabbit antiserum to mouse E-eadherin (uvomorulin; generously provided 
by Dr. R. Kemler) and mouse 46-kd cytokeratin (provided by Dr. E. Reich- 
mann) were used similarly. Basically, ceils were fixed with 3.7% 
paraformaldehyde plus 0.01% glutaraldehyde at 4°C for 15 rain, and then 
permeabilized with 0.1% NP-40 in medium for an additional 15 min at room 
temperature. Antibodies were used at the dilutions recommended by the 
manufacturers in a final volume of 50 t~l. After a l-h incubation at room 
temperature, the plates were washed with PBS and stained with second anti- 
body (FITC-conjugated anti-mouse or anti-rabbit IgG, Amersham, diluted 
1:50) for 1.5 h. After staining, cells were washed three times with PBS, 
mounted in Mowiol (HOECHST), and viewed using a Zeiss Axiophot fluo- 
rescence microscope with epiillumination. 
RNA Preparation and Northern Analysis 
Total RNA was prepared using the guanidinium isothiocyanate-phenol- 
chloroform procedure (Chomczynski and Sacehl, 1987). Purification of 
poly(A) + RNA was done as described (Vermstrtm and Bishop, 1982). 
Northern blots were performed on Gene Screen membranes (New England 
Nuclear, Boston, MA) according to standard protocols (Maniatis et al., 
1982). All probes were labeled by the random priming method (Feinberg 
and Vngelstein, 1983) using commercial kits (Pharmaeia LKB Bioteehnol- 
ogy Inc., Piscataway, NJ). Source of probes: rat c-erbA/TR~l from Dr. 
R. M. Evans, rat TR-/3 from Dr. H. C. Towle, mouse c-jun,junB, andjunD 
and integrin-fll from Dr. R. Bravo, ratfra-1 from Dr. T. Curran, rat NGFI-A 
and NGFI-B from Dr. J. Milbrandt, v-fos from Dr. E. Wagner, rat transin 
from Dr. R. Breathnaeh, mouse collagen cd (I) from Dr. Z. Q. Wang, rat 
SCG10 from Dr. D. J. Anderson, rat GAP-43 from Dr. M. C. Fishman, rat 
tyrosine hydroxylase from Dr. E. Ziff, rat chromogranin B from Drs. S. 
Forss-Petter/J.G. Sutcliffe, mouse N-CAM from Dr. C. Goridis, mouse 
cytokeratin (endoB/K18) from Dr. M. Busslinger, human trk from Dr. M. 
Barbaeid, mouse trk from Dr. L. Parada, rat LNGFR from Dr. E. M. 
Shooter, human RARer and mouse RARfl from Dr. H. Stunnenberg, and 
rat NF68 from Dr. E Grosveld. Rat MASH-I and MASH-2 genes were 
cloned from poly (A) + RNA prepared from dense cultures of PC12 6c cells 
by eDNA synthesis and PCR amplification using primers pecific for the 
extremes of the published sequences (Johnson et al., 1990) obtained from 
the EMBL data bank. The oligonueleotides u ed were 5'AATATAATG- 
AAGC~GCGTTTCTTCCCTTrTAAC 3' and 5'TATGA'IV_.AAGAA- 
TTCCATCC'IV_~'VICCAAAGTCCAT 3' for MASH-1 and 5'AATATAATG- 
AAGCTTGTCGAGGACGCATTAAGC 3' and 5'TATGATCAAGAATTC- 
CAAGTCCTGGTTTC~ 3' for MASH 2. The amplified products 
were cloned into the HindIII and EcoRI sites of the pRK7 plasmid. Frag- 
ments covering the nonhomologous 3' ends were prepared as specific probes 
for both genes. A 308-bp PvulI fragment was prepared for MASH-1 and 
a 397-bp PstI-ScaI fragment for MASH-2. Hybridizations were carried out 
overnight at 65"C in 7% SDS, 500 mM sodium phosphate buffer, pH 7.2, 
and 1 mM EDTA according to Church and Gilbert (1984). Filters were 
washed twice for 30 rain each in 1% SDS and 40 mM sodium phosphate 
buffer, pH 7.2, at 65"C. Before rehybridizing the nylon membranes with 
probes for other genes, the radioactive probe was stripped off the membrane 
by placing it in a 750C water bath for 5 min. 
Results 
Stable Expression of Exogenous erbA Genes 
in PC12 Cells 
To analyze the possible role of T3 and its receptor on PC12 
differentiation in vitro, we sought o stably express the avian 
c-erbA/TR~-I protein as well as its oncogenic variant, v-erbA, 
in these cells. Cultures of a clonal PC12 subline (6c, see 
Materials and Methods) were infected with retroviruses ex- 
pressing c-erbA/TRa-1 or v-erbA together with the neo r
gene as a selectable marker. Several neoresistant clones of 
c-erbA/TR,-I infected cells were obtained. In contrast, we 
only succeeded to expand a pool of v-erbA-infected cell 
clones due to their poor clonal proliferation ability. 
The expression of the respective TR~-I and v-erbA pro- 
teins was monitored by immunoprecipitation using anti- 
erbA antisera, c-erbA/TR~-I protein was just detectable, 
whereas v-erbA was expressed athigh levels, comparable to
those found in avian erythroleukemic cells (Fig. 1 A). Syn- 
thesis of active c-erbA/TRa-1 protein was confirmed by a 
hormone binding assay after incubation with ~25I-labeled 
%. Specific binding was one order of magnitude higher in 
c-erbA/TRcel-expressing cellsthan in uninfected or v-erbA- 
expressing cells (Fig. 1 B), and of the same order of magni- 
tude as that of rat GH1 pituitary cells containing a few thou- 
sand active receptor molecules per cell (Samuels et al., 
1976, 1977). 
Endogenous Hormone Receptor Expression 
in Normal and erbA-expressing PC12 Cells 
Since several cell lines of neural origin express the thyroid 
hormone receptor variant TRot-2 in high excess over TRot-1 
(Mufioz, A., J. Bernal, and A. Rodriquez-Pefia, unpublished 
observations), we tested if this was also true for PC12. As 
shown by Northern blot analyses, normal PCI2 cells ex- 
pressed much higher levels of the TRot-2 form than of the 
TRot-1 and TRfl receptors (Fig. 1 C). In contrast, he retrovi- 
rus transduced exogenous c-erbA/TRot-1 and v-erbA genes 
were expressed at levels comparable to those of the endoge- 
nous TRtx-2 receptor. Thus, the nonresponsiveness of PC12 
cells to T3 may in fact be due to functional suppression of 
the low TRa-I levels by an excess of TRt~-2. 
To rule out that the c-erbA/TRct-1- and v-erbA-expressing 
PC12 sublines were altered in their expression of other im- 
portant receptors, the same blots were hybridized with cDNA 
probes encoding the low (gp80 ENG.) and high (gpl40 ~k) 
affinity NGF receptors as well as the retinoic acid receptors 
(RARs) ot and/~. All these receptors were expressed in the 
parental cells (distinct signal from 10 #g total RNA after 5-d 
exposure) and no changes in expression levels were detected 
in the sublines expressing exogenous erbA proteins (data not 
shown). 
Ligand-activated TRa-1 Renders PC12 Cells 
NGF-dependent for Proliferation and Survival 
Neurotrophic factors such as NGF are considered to be 
necessary for survival of differentiating neuronal cells, in- 
cluding primary adrenal medulla sympathetic neurons in 
culture. (Doupe et al., 1985b; Anderson and Axel, 1986). 
In contrast, PC12 cells grow in the absence of NGF, and re- 
vert to an undifferentiated state if the factor is withdrawn af- 
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Figure L ErbA expression i PC12 cells. (.4) Unin- 
fected, TRot-1/c-erbA- and v-erbA-infected PC12 
cells were labeled with [35S]methionine and ly- 
sates from equal numbers of cells were immuno- 
precipitated with an antibody against v-erbA. The 
immunoprecipitates w re analyzed on 10% SDS- 
polyacrylamide gels and fluorographed. Films 
were exposed for 6 d. Bands corresponding to the 
chicken p46 ¢-e~bA and the viral p75 ~-v-e'~/' are indi- 
cated by arrows. The faint p46 c'erbA band is also 
indicated by a solid triangle to distinguish it from 
two bands precipitated nonspecifically (open tri- 
angles). (N) preimmune serum; (I) immune se- 
rum. (B) Uninfected and infected PC12 cells were 
analyzed for T3-specific binding as described (Sap 
et al., 1986; Mufioz et al., 1990), in presence 
(+T3) or absence (-T3) of a 1,000-fold molar ex- 
cess (0.3 #M) of cold T3 as competitor. Rat pitui- 
tary GH1 cells expressing high levels of endog- 
enous T3 receptors were used as a control. (C) 
Analysis ofTR RNA expression by Northern blots in uninfected, TRot-I- and v-erbA-infected PC12 cells. 10 #g of total RNA were analyzed 
per lane. Exposure times: rat c-erbA/TR-ot, 6 d; rat c-erbA-TR/[3, 14 d. Mature endogenous TRot-1 RNA (lower band, 5 kb) and its precur- 
sor (upper band, 6.5 kb) are indicated with asterisks (*). The band corresponding to the endogenous TRot-2 RNA (2.6 kb) is marked 
with an (x). It coincides with that of the viral subgenomic RNA encoded by the internal promoter. This RNA, as well as the large unspliced 
viral genomic RNAs (indicated by arrows) crosshybridize with both rat c-erbA probes, ot and/3. Hybridization with the/3 probe gives 
two very weak signals corresponding to the precursor (6.5 kb, arrowhead) and mature (4 kb) RNAs. 
ter induction of differentiation. To determine whether TRc~-I 
expression would affect PC12 cells responsiveness to NGF, 
we first studied the effects of T3, NGF, or their combination 
on the capacity of uninfected and erbA expressing cells to 
proliferate and to synthesize DNA. 
As shown in Fig. 2, treatment with NGF alone or NGF 
plus T3 did not grossly affect proliferation of uninfected 
cells (panel A, left). In cells expressing exogenous TRot-1 
however, T3 and NGF had clear but opposite ffects on sur- 
vival and proliferation. NGF alone led to a drastic increase 
Figure 2. Effects of T3 and 
NGF on the proliferation and 
survival of uninfected, TRot-l- 
and v-erbA-PC12 cells. (A) 
Proliferation capacity of the 
three cell types was analyzed 
after 5 d of treatment with 
NGF, T3, or both hormones 
(NGF + T3) by measuring 
the incorporation of tritiated 
thymidine into trichloroacetic 
acid-precipitable material (see 
Materials and Methods). Hori- 
zontal bar indicates the incor- 
poration level (100%) of the 
corresponding untreated con- 
trol cells. (B) TRot-l- and 
v-erbA-PC12 cells were treated 
for 7 d with NGF plus T3, and 
then incubated with T3 alone 
(circles), NGF alone (trian- 
gles), or no hormone (inverted 
triangles). Surviving cells were 
counted 2 and 3 d later after 
extensive washing of the mono- 
layers. Hundred percent val- 
ues correspond to cell num- 
bers obtained with each cell 
type after the initial 7-d NGF 
plus T3 treatment. (C) TRa- 
1-PC12 cells were incubated with mitomycin C (Mit. C, see Materials and Methods) or left untreated (Control). They were then incubated 
with NGF for 6 d (+ NGF) or with NGF-free medium (no NGF). Phase micrographs of these cells (middle and lower panels) as well 
as of respective uninfected PC12 cells induced to differentiate with NGF are shown (upper panels). Bar, 50 #m. 
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in the level of DNA synthesis (Fig. 2, panel A, middle) which 
was reflected by a 30 % increase in cell number after 5 d (not 
shown). T3 had an opposite ffect: DNA synthesis ceased, 
and cells no longer divided and degenerated progressively. 
None of these effects were observed upon combined treat- 
ment with NGF and T3. 
These observations suggested that ligand-activated TRot-1 
indeed rendered PC12 cells dependent for survival and 
proliferation on neurotrophic factors like NGE To confirm 
this, cells were pretreated for one week with NGF + T3, 
and then cultured in medium containing no additions of ei- 
ther T3 or NGF separately. When switched to T3 containing 
medium, more than 80% of TRot-1 cells degenerated within 
3 d (Fig. 2 B), while they survived as differentiated cells in 
control cultures containing NGF + T3 (see below). A 
significant proportion of TRot-1 cells died even in plain 
medium and only NGF was able to prevent cell death. V-erbA- 
expressing cells were completely refractory to any of these 
treatments (Fig. 2 B), while normal, uninfected cells showed 
weak, intermediate responses (data not shown). Whether or 
not the cells died by programmed cell death (apoptosis) after 
removal of NGF as shown to take place during normal CNS 
development in vivo (for review see Oppenheim, 1991) is 
still under investigation. 
C-erbA/TRa4 and v-erbA Affect NGF-induced 
Neuronal Differentiation i  PC12 cells 
To determine whether TRot-1 or v-erbA expression affects 
the ability of PC12 cells to differentiate into neurons in re- 
sponse to NGF, uninfected cells, and cells expressing c-erbA/ 
TRot-1 or v-erbA were treated with NGF, T3, or both for 
5-7 d. The extent of neuronal differentiation was estimated 
by monitoring neurite outgrowth and expression of two nell- 
ronal markers, synaptophysin a d N-CAM (Prentice t al., 
1987; Mann et al., 1989), on neurites and cell bodies by im- 
munofluorescence. As controls, cells were stained with anti- 
bodies to tyrosine hydroxylase (TH), an enzyme which is 
downregulated byNGF but induced by dexamethasone dur- 
ing chromaffin differentiation (Lewis et al., 1983; Leonard 
et al., 1987; Stein et al., 1988b), and to glial fibrillary acidic 
protein, an astrocyte marker. 
As expected, NGF treatment of uninfected cells induced 
cell flattening followed by appearance and progressive elon- 
gation of neurites and rounding of cell bodies (Fig. 3). The 
neurites expressed high levels of synaptophysin a d lower 
levels of N-CAM, while TH expression decreased (from 55 
to 16% fluorescence positive cells; Fig. 3). As mentioned 
above, T3 alone had no major effects on normal PC12 cells 
and did not detectably alter NGF-induced differentiation, 
when applied together with NGF (data not shown). 
In contrast, expression of exogenous TRoe-1 strongly ar- 
rested NGF-induced ifferentiation. When treated for 6 d 
with NGF alone, the cells developed only short processes 
that failed to elongate ven after prolonged NGF application 
(Fig. 4). TRot-l-cells also failed to upregulate synaptophysin 
and N-CAM expression i response to NGF (Fig. 4 and data 
not shown). TH content was low already in the uninduced 
stage (20% positive cells) and was further reduced after 
NGF (2.5% positive cells, not shown). 
Interestingly, the differentiation block could be completely 
reversed by addition of T3 together with NGE After 6 d of 
exposure to both agents, a high proportion of TRot-1 cells 
produced long processes xpressing synaptophysin and N-CAM 
at similar or even higher levels as uninfected cells in the pres- 
ence of NGF alone (compare Figs. 3 and 4, data not shown). 
In the absence of NGF, T3 induced progressive cell death 
which affected 30-80 % of the population after 5 d depending 
Figure 3. NGF-induced neu- 
ronal differentiation of clonal 
PC12 6c ceils. Phase micro- 
graphs of uninfected PC12 6c 
cells treated with NGF for 7 d 
(+ NGF) see Materials and 
Methods) or left untreated 
(Control) are shown (left pan- 
els). Parallel cultures were 
stained with antibodies against 
synaptophysin, tyrosine hy- 
droxylase, N-CAM, and glial 
fibdllary acidic protein (GFAP, 
negative control), and photo- 
graphed (see Materials and 
Methods). Bar, 50/zm. 
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on the clone analyzed (Fig. 4, lower panels and data not 
shown). 
Cells expressing v-erbA showed a distinctly different re- 
sponse. They were arrested in neuronal differentiation 
regardless of whether the cells were treated with NGF alone 
or in combination with T3 (Fig. 4). In both cases, they 
formed only short processes that expressed no synaptophysin 
with NGF alone, while some expression was seen at the neu- 
rite tips with NGF + T3 (Fig. 4). This latter result agrees 
with the assumed role of v-erbA as a constitutive repressor 
of TR-regulated genes (Sap et al., 1989; Damm et al., 1989). 
T3 alone had no effect on these cells. 
Since cells expressing TRa-1 were induced by NGF to 
grow at an increased rate we had to rule out that their 
differentiation arrest was a consequence of an increased 
proliferation and cell density. To rule out this possibility cell 
differentiation was studied after inhibition of cell prolifera- 
tion with mitomycin-C. Uninfected PC12 cells differentiated 
normally in response to NGF in presence or absence of 
mitomycin-C (Fig. 2 C, upper panels). In contrast, both 
mitomycin-treated and control TRc~-I cells formed only 
short processes inresponse to NGF (Fig. 2 C). This suggests 
that the stimulation of proliferation and the differentiation ar- 
rest caused by TRu-1 in NGF-treated PC12 cells are un- 
related phenomena. 
Retinoic Acid Receptors Do Not Play 
a Major Role in TRu4 Regulated Neuronal 
Differentiation of PC12 Cells 
Since PC12 cells express retinoic acid receptors (RARol and 
RAR/~) and cooperation of TRs and RARs is thought o be 
crucial for thyroid hormone action in several systems (Hud- 
son et al., 1990; Schroeder et al., 1992b), we determined 
whether etinoic acid (RA) would affect Trdependent regu- 
lation of differentiation in normal and TRol-l-expressing 
PC12 cells. In either cell type, RA did not grossly affect neu- 
ronal differentiation i duced by NGF or NGF + T3. Also, 
RA did not alter the T3-induced NGF dependence of TRot-1 
cells. However, if used alone, RA seemed to induce cell 
rounding and formation of aggregates similar to those seen 
during the initial stages of dexamethasone-induced chro- 
Figure 4. Arrest of NGF-in- 
duced neuronal differentiation 
by TRa-I and v-erbA. Phase 
micrographs of TRot-1 and 
v-erbA-expressing PCI2 cells 
treated with NGE NGF plus 
T3 (7 d) or T3 alone (5 d), or 
left untreated (Control) are 
shown. Middle panels (TRc~-I) 
and insets to right panels 
(v-erbA) show the correspond- 
ing immunofluorescence anal- 
ysis using synaptophysin anti- 
body (see Materials and 
Methods). Bar, 50 #m. 
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marlin differentiation (data not shown). Again, this response 
was not affected by the presence or absence of exogenous 
TRot-I, suggesting that the RARs do not play a major role in 
the regulation of neuronal differentiation by TRot-1. 
TRa4 Does Not Affect he Induction 
of Early Genes by NGF 
Several dozen genes are known to be induced by NGF in 
PC12 cells (for a review see Halegoua et al., 1991). These 
genes can be distributed in two groups: early response g nes 
whose induction begin a few minutes after NGF addition and 
peak one or a few hours later, and late response genes which 
are induced with slower kinetics and reach their maximum 
level of expression two, four, or more days after continuous 
NGF treatment. 
First, we analyzed possible effects of TRot-1 on the expres- 
sion of NGF-inducible early genes, such as c-jun, jun-B, 
jun-D, c-fos, fra-1, NGFI-A (Krox 24, egr-1, zif1268), and 
NGFI-B (nur/77, N10) which have been reported to be in- 
duced by NGF to a variable xtent (Greenberg et al., 1985; 
Kruijer et al., 1985; Morgan and Curran, 1986; Milbrandt, 
1987, 1988; Bartel et al., 1989; Szebertnyi et al., 1990). 
Thefra-1 gene was particularly interesting, since its constitu- 
tive expression apparently blocks induction of many of the 
other early genes (Ito et al., 1990). Uninfected and TRot-l- 
expressing cells were treated for 1 h with NGF, T3 or both 
hormones, and subjected to Northern blot analysis, using 
poly(A) + RNA (Fig. 5). 
NGF caused a similar transient upregulation of all these 
genes in uninfected and TRot-I-expressing cells with strong 
increments of mRNA levels after 1 h, and much less after 
24 h. Furthermore, T3 neither superinduced norsuppressed 
the induction of any of these genes by NGF in either cell type 
Figure 5. TRot-1 does not af- 
fect expression of NGF-induced 
early genes. Northern blot anal- 
yses for expression of NGF- 
induced early genes were p r- 
formed with uninfected (PC12) 
and TRot-l-expressing PC12 
cells (PC12 + TRa-1) treated 
for 1 (1 h) or 24 h (24 h) with 
NGF, T3 or both (NGF + T3), 
or left untreated (-). Expres- 
sion of cyclophilin mRNA was 
used as control. 2.5 /zg poly 
(A) + RNA were loaded per 
lane. Exposure times: fra-l, 
3 d; c-fos, 3 d; c-jun, 1 d;jun 
B; 16h;jun D, 16h; NGFI-A, 
4 h; NGFI-B, 16 h; and Cyclo- 
philin, 16 h. 
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(Fig, 5 and data not shown). Similar patterns were obtained 
for ornithine decarboxylase (not shown). These results how 
that TRot-1 does not interfere at all with NGF-regulated early 
gene expression, indicating that NGF is able to induce all its 
normal intracellular signals in TR~l-expressing PC12 cells. 
TRa-I  Causes Hormone-dependent Repression 
of NGF-induced Late Genes 
Having ruled out hat TRot-1 affects NGF-dependent signal 
transduction, we checked the alternative hypothesis that 
TRa,-1 might block the expression of neuronal-specific genes 
in absence of ligand, but allow or even enhance their NGF- 
regulated expression in presence of T3. Such a result would 
be expected from a similar behavior of TRt~-I in transient 
transfection experiments (Damm et al., 1989; Sap et al., 
•989) as well as in avian erythroblasts (Zenke et al., 1988, 
1990). Consequently, cells were treated with NGF alone, 
NGF + T3, or left untreated, and tested for late gene ex- 
pression in Northern blots. 
TRa-1 strongly affected expression of a large series of 
NGF-inducible late genes (Fig. 6). This group consisted of 
Figure 6. T3-dependent regu- 
lation of NGFqnduced late 
genes by TR~x-1. Expression 
analysis of NGF-induced late 
genes (upper pane/s), MASH-I 
(middle panels), and of two 
chromaflin marker genes (low- 
er panels) by Northern blot 
hybridization vats performed 
in uninfected, TRa-1- and 
v-erbA-expressing PC12 cells 
after treatment with NGF,  
+ T3, or no hormone (-)  for 
1 and 24 h as weU as for 3 
(3 d) or 6 d (6 d) as described 
in the legend to Fig. 5. l0/~g of 
total RNA vcere loaded per lane. 
Exposure times: MASH-I, 1 
a_nd 24 h, 20d; 6d, 14d; Tmn- 
sin, 3 d; SCGIO, 3 d; NF68, 
6 d; Integrin/3, 6 d; Collagen 
cd(I), 4 d; N-CAM, 6 d; GAP- 
43, 6 d; TH, 16 h; (~romogra- 
n/n B, 7 h; and Cyc~philin, 2 d. 
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four neuron-specific genes (SCG10, neurofilament 68, N-CAM, 
and GAP-43; Prentice et al., 1987; Stein et al., 1988a,b; 
Lindenbaum etal., 1988; Federoffet al., 1988), the protease 
transin probably involved in neurite outgrowth (Machida et 
al., 1989) and extracellular matrix proteins and their recep- 
tors (collagen-otl [1], integrin-fll; Mann et al., 1989; Van 
Hoof et al., 1989; Costello et al., 1990). In absence of T3, 
TRot-1 efficiently repressed upregulation fall these genes by 
NGF. Exposure of the cells to NGF plus T3 stimulated ex- 
pression of all genes to similar or even higher levels than ob- 
served in normal PC12 cells induced to differentiate byNGF 
alone or by NGF + T3. In addition, several of these genes 
(e.g., SCG-10, integrin-fll) appeared to be repressed inPC12 
cells expressing unliganded TRot-1 (Fig. 6). A similar pat- 
tern was found for two additional genes (peripherin and 
MAP-2) that were only weakly induced by NGF (data not 
shown). Thus, TRot-1 regulates neuronal gene expression i
a fashion faithfully reflecting its effect on morphological 
differentiation. 
TRt~4 Does Not Affect NGF-induced Repression 
of the Early Neuroblast Marker MASH-1 
The MASH-1 and MASH-2 genes, rat homologues of the 
Drosophila chaete-scute genes probably involved in neu- 
ronal development, were recently isolated as candidates for 
neuronal "master" genes (Johnson et al., 1990). Later work 
suggested that the MASH-1 gene may be a marker for early 
neuronal progenitors and that NGF causes the loss of this 
early marker in PC12 cells (Lo et al., 1991). Because of their 
possible significance for neuronal differentiation, it was of 
interest to study if MASH gene expression was regulated by 
TRot-1. 
Northern blot analysis revealed no detectable expression 
of the MASH-2 gene (not shown). MASH-1 mRNA levels 
remained unchanged in normal and TRot-1 cells after 1 h 
treatment with NGF or NGF + T3 (Fig. 6). Treatment for 
24 or 144 h with these agents caused a significant decrease 
in MASH-1 mRNA levels in both cell types, although down- 
regulation of MASH-1 message by NGF alone occurred 
more slowly in the TRot-l-expressing cells. These findings 
agree with those from Lo et al. (1991) and confirm our results 
on the early NGF-induced genes, suggesting that TRot-1 does 
not simply block NGF action, but causes a late arrest in 
PC12 differentiation via an NGF-independent pathway. 
TRot4 Prevents Entry of PC12 Cells into the 
CbromaJfin Differentiation Pathway 
Having shown that TRot-1 regulated neuronal differentiation 
and gene expression in a hormone-dependent fashion, we 
next investigated whether TRot-1 might affect he alternative 
differentiation pathway open to PC12 cells, i,e., chromaffin 
differentiation induced by dexamethasone (DEX). DEX was 
reported to cause morphological changes and expression of 
some chromaftin markers in PC12 cells (Greene and Tisch- 
ler, 1982) and to antagonize the action of NGF at the molec- 
ular level (Leonard et al., 1987; Stein et al., 1988b). 
After prolonged DEX treatment (20 d), uninfected PC12 
cells adopted arounded or polygonal shape, strongly adher- 
ing to each other, and formed cords and clumps which even- 
tually fused into compacted epithelioid islands. This pheno- 
type was not altered by the presence of T3. In contrast, 
DEX-treated TRot-1 cells showed adelay in the formation of 
cell clumps which failed to develop into dense, compact is- 
lands. In presence of T3, the cultures contained even more 
individual cells and few loose clumps, cells displaying a po- 
lygonal shape and short neurite-like spikes (data not shown). 
These pilot studies raised the possibility that TRot-1 in- 
hibited DEX-induced differentiation of PC12 ceils into 
epithelioid, chromaffin-like c lls. This was confirmed by the 
pattern of expression of epithelial markers uch as cytokera- 
tins and E-cadherin (uvomorulin). Strong expression of 
cytokeratins and weak, but distinct expression ofmembrane- 
bound uvomorulin was seen in the epithelioid islands ob- 
tained from DEX-treated uninfected cells. Expression of 
both markers was essentially missing in the loose groups of 
TRot-l-expressing cells subjected to the same treatment (data 
not shown, see below). We also studied the expression of the 
chromaffin marker TH. As expected, TH was strongly up- 
regulated by DEX in uninfected cells (55->98% strongly 
positive cells, Fig. 7 A). In contrast, TRot-1 cells expressed 
only low levels of TH (<10% weakly positive cells), which 
were only weakly upregulated byDEX (<30% positive cells; 
Fig. 7 A). 
Differentiation of uninfected PC12 cells induced by 
prolonged DEX treatment was irreversible (Fig. 7 B). Even 
after DEX removal and subsequent treatment with NGF or 
NGF + T3 most cells remained forming epithelioid islands 
expressing chromaffin markers (cytokeratin and uvomoru- 
lin). In contrast, TRot-1 expression prevented irreversible 
chromaffin differentiation. TRot-1 cells treated sequentially 
with DEX and NGF appeared immature with numerous 
short neurites and failed to express uvomorulin or cytokera- 
tin (except for a low percentage ofcytokeratin-positive cells; 
Fig. 7 B). As expected, if T3 was administered together 
with NGF the cells differentiated into neurons. These results 
indicate that TRot-l-expressing PC12 ceils respond abnor- 
mally to DEX induction. Instead of differentiating into 
chromaffin cells, they retain an undifferentiated phenotype 
and remain inducible by NGF + T3 to form neurons. Thus 
TRot-1 constitutively prevents entry of PC12 ceils into the 
chromaffin pathway, raising the possibility that TRot-1 ex- 
pression commits the cells to the neuronal pathway of 
differentiation. 
The effect of TRot-1 in blocking entry into the chromaffin 
pathway was also confirmed by studying the expression of 
two genes, TH and chromogranin B which although ex- 
pressed in neurons are induced by DEX during chromaffin 
differentiation f PC12 cells (Lewis et al., 1983; Leonard et 
al., 1987; Stein et al., 1988b). Both basal and DEX-induced 
expression of TH was blocked in cells expressing TRot-1 
(Figs. 6 and 8). Neither NGF nor T3 or both could release 
the suppression of TH mRNA levels (Fig. 6). A much 
weaker suppressive ffect of TRot-1 was observed for the 
chromogranin B and cytokeratin genes. 
V-erbA Constitutively Induces 
an Aberrant Phenotype Combining Neuronal 
and Chromaffin Characteristics 
The v-erbA oncogene acts as a constitutive r pressor of red 
cell differentiation a d erythrocyte gene expression i avian 
erythroblasts (Zenke t al., 1988, 1990; Disela et al., 1991). 
It also interferes with transactivation f synthetic TR/RAR 
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Figure 7. Effects of TRc~-I and v-erbA on dexamethasone-induced chromaflin differentiation in PC12 cells. (.4) Immunotluorescence analysis 
of tyrosine hydroxylase protein expression in uninfected, TRc~-I-, and v-erbA PCI2 cells treated with dexamethasone for 2 wk (DEX) or 
left untreated (Control.) Bar, 50 #m. (B) (Upper group ofpanels; Morphology) Uninfected PC12 cells and TRct-I-PCI2 cells were treated 
for 20 d with dexamethasone. They were then washed and incubated fora  additional 7 d with NGF (Dex~NGF) or NGF + T3 (DEX 
~NGF + T3). Phase micrographs of representative areas are hown. Note presence of dense epithelioid islands surrounded by neuron- 
like cells in the normal PC12 cells. Bar, 50 #m. (Lower group of panels) Immunofluorescence analysis on parallel dishes to those photo- 
graphed in the upper panels, using uvomorulin (E-cadherin) and cytokeratin antibodies, is shown. 
response lements by RARot (Sharif and Pfivalsky, 1991) and 
has been claimed to prevent inhibition of fibroblast prolifera- 
tion by RA (Desbois et al., 1991). We therefore studied in 
more detail how v-erbA affected ifferentiation and gene x- 
pression in PC12 cells. 
As already described above, v-erbA expression caused a 
constitutive, partial inhibition of NGF-induced neuronal 
differentiation, regardless of the presence or absence of thy- 
roid hormone (Fig. 3). In contrast to TRot-1 cells, DNA syn- 
thesis and cell proliferation were not affected by NGF or T3 
treatment in v-erbA cells (Fig. 4 A). Most strikingly, T3 did 
not induce an NGF dependence for cell survival, and even 
the weak cytopathic effect induced by T3 alone in unin- 
fected cells was completely absent in v-erbA expressing cells 
(Fig. 4 B). This protective ffect of v-erbA may well be due 
to suppression of endogenous c-erbA action. 
Similarly to TRot-I, v-erbA did not affect he induction of 
early genes by NGF (Fig. 5). In contrast to TRot-I, however, 
v-erbA did not cause a repression of most late NGF inducible 
genes studied (Fig. 6) and was not able to prevent heir in- 
duction by NGE As expected from the inability of the v-erbA 
protein to bind and respond to hormone (Sap et al., 1986; 
Mufioz et al., 1988, 1990, see Fig. 1), T3 did not alter ex- 
pression levels of most NGF-inducible genes in v-erbA ceils. 
The transin (stromelysin) gene was an interesting excep- 
tion. Induction of this gene by NGF was strongly inhibited 
in v-erbA ceils as compared to normal PC12 cells (Fig. 6). 
This repression persisted even after incubation with NGF + 
T3, leading to much lower levels of transin mRNA than ob- 
tained in normal or c-erbA cells treated similarly. It seems 
possible, therefore, that v-erbA is able to constitutively re- 
press a subset of NGF-inducible genes, in line with its ability 
to partially inhibit neuronal differentiation. 
Finally, v-erbA had an unexpected effect on DEX-induced 
chromatfin differentiation and gene expression. Treatment of 
v-erbA cells with DEX caused their flattening and aggrega- 
tion into small groups, but epithelioid islands were not ob- 
served even after prolonged DEX treatment. In line with this 
finding, no E-cadherin could be detected on the cell mem- 
branes by immunofluorescence (data not shown). However, 
the cells expressed constitutively elevated levels of cytokera- 
tin and TH. Even in untreated cells, staining with TH and 
cytokeratin antibodies was very strong (Fig. 7 A and data not 
shown) and even increased after DEX treatment (Fig. 7 A). 
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Figure 8. Induction of chro- 
marlin and epithelial genes in 
erbA-expressing PC12 cells. 
Northern blot analyses of 
tyrosine hydroxylase (TH), 
chromogranin B, and cyto- 
keratin mRNA expression was 
performed using uninfected, 
TRcz-1, and v-erbA-PC12 
cells. Cells were treated with 
DEX, DEX + T3 for 6 (6 d) 
or 14 d (14 d), or left untreated 
(-). As controls, cyclophilin 
expression was determined. 
10 #g of total RNA were 
loaded per lane. Exposure 
times: TH, 7 h; Chromogranin 
B, 4 h; 46 kd Cytokemtin, 3 d; 
and Cyclophilin, 2 d. 
The results obtained for chromaffin marker gene expres- 
sion were in line with these observations. Untreated or NGF- 
treated v-erbA cells expressed significantly higher levels of 
TH, chromogranin B, and cytokeratin messages than the 
respective uninfected c ils (Fig. 8). However, DEX was still 
able to further induce these genes to similar levels in both 
normal and v-erbA-expressing ceils. This suggests that v-erbA 
constitutively upregulates chromaffin marker gene expres- 
sion, but does not prevent heir regulation by DEX (Fig. 8). 
A summary of the effects of c-erbA/TRot-1 and v-erbA on 
PC12 cell differentiation and survival is represented in Fig. 9. 
To rule out the trivial possibility that our v-erbA-PC12 
cells fail to differentiate because of irreversible cell line 
progression changes, we tried to induce differentiation in 
Figure 9. Schematic representation of how TRot-1 
and v-erbA regulate PC12 cell differentiation i to 
neurons and chromaffin cells. (Upper panels) In
both presence and absence of '1"3, normal PC12 
cells differentiate into neurons or chromaflin cells 
upon NGF or dexamethasone treatment, r spec- 
tively. They are independent of NGF for growth 
and survival in the absence of Ta and exhibit a 
weak or absem NGF dependence (+/- )  in its 
presence. (Middle panels) TRot-l-expressing 
PCl2 cells are partially blocked (black bar across 
arrow) in their capacity to differentiate into either 
neurons or chromaflin cells in the absence of T3. 
Upon T~ addition, these cells respond normally 
to NGF, becoming neurons. In contrast, differenti- 
ation into more mature chromaflin cells remains 
blocked in the presence of T3. TRot-1 cells are 
strongly dependent (+++) on NGF for survival 
when 1"3 is present. (l_znverpanels) V-erbA-PC12 
cells are partially blocked for NGF-induced neu- 
ronal differentiation regardless of the presence or 
absence of 1"3. They exhibit a probably aberrant 
phenotype combining neuronal and chromaflin 
markers (indicated by altered cell shape) in the 
presence of dexamethasone. They do not respond 
at all to T3 (-). 
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these cells by an alternative pathway. Cyclic AMP has been 
shown to induce part but not all of the NGF-induced pheno- 
typic and gene expression changes in PC12 cells, most likely 
via pathway(s) independent of those important for NGF 
action (see Halegoua et al., 1991). Indeed, NGF plus di- 
butyryl-cAMP (0.1 mM) induced istinct morphological 
differentiation characterized bytypical ong neurites in both 
TRct-1- and v-erbA-expressing PC12 cells. In line with pub- 
lished work (Gunning et al., 1981), dibutyryl cyclic AMP 
alone at high concentrations (1 mM) also induced partial 
differentiation i  both cell types. Thus, the v-erbA-induced 
differentiation arrest cannot be due to mutational changes in 
our cell lines. 
Spontaneously Immortalized Rat Brain Neuroblasts 
Differentiate inResponse to T~ and NGF 
after Introduction of an Exogenous TR~-I Gene 
Since TRot-1 has no reported function in differentiation of
normal adrenal medulla progenitors, the possibility re- 
mained that our results employing the PC12 cell system rep- 
resented the aberrant behavior of a tumor cell line, mimick- 
ing normal differentiation processes as a consequence of
artificial experimental treatments. We therefore sought o 
demonstrate aneffect of TRu-1 in neuroblasts derived from 
the CNS, where the involvement of thyroid hormone recep- 
tors in neuronal maturation is amply documented (see in- 
troduction). Consequently, we introduced the avian TRot-1 
into the E 18 cell line, which has been obtained by spontane- 
ous immortalization from cultures of 17-d rat embryonic 
brain (Seliger, B., unpublished observations). E 18 cells rep- 
resent primitive neuroblasts that express NF 68 and the 
primitive neuronal marker nestin, but lack the astrocyte 
marker, glial flbrillary acidic protein. After partial differen- 
tiation induction with dibutyryl-cAMP, the cells express fur- 
ther neuronal markers such as NF 145, NF 220, and neuron- 
specific enolase. Similarly to PC12 ceils, the El8 cells ex- 
pressed only low levels of TRt~-I together with high levels 
of TRet-2 (data not shown). 
To test the ability of TRt~-I expressing E 18 cells to 
differentiate in response to NGF, T3 or both, we used an E 
18 clone infected with the TRt~-I retrovirus as described for 
PC12 cells. This clone expressed TRcM at similar levels as 
the TRot-1 PC12 clone cA4 (data not shown). As shown in 
Fig. 10, TRot-1 E 18 cells failed to differentiate in response 
to NGF alone, a property shared with uninfected E 18 ceils. 
Also, NGF seemed not to influence E 18 cell proliferation. 
Upon T3 addition, cells became less adherent and partially 
disintegrated (Fig. 10, T3) mirroring the cell killing effect 
observed in PC12 cells. In presence of both NGF and T3, 
however, essentially all cells underwent massive neuronal 
differentiation characterized by outgrowth of long neurites 
Figure 10. T3 plus NGF in- 
duce differentiation in TRc~-I 
expressing E 18 neuroblasts 
derived from embryonic rat 
brain. Phase micrographs are 
shown from E 18 cA9 cells 
cultivated in serum-free differ- 
entiation medium for 6 d in 
absence (Control) or presence 
of T3, NGF, or both (NGF + 
/'3). Note effective differentia- 
tion into neuron-like cells upon 
treatment with both NGF and 
T3 (panel NGF + T3) Inset: 
Some of the neuron-like cells 
obtained with NGF + T3 in a 
separate experiment at higher 
magnification. Note also cell 
disintegration (refractile small 
bodies) in the Ta-treated cul- 
tures. Bar, 50/xm. Inset: bar, 
20/~m. 
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within 6 d, often in a bipolar fashion (Fig. 10). Thus, TRcM 
expression in CNS derived neuroblasts conferred respon- 
siveness to T3 in a fashion very similar to that observed in 
TRc~-I expressing PC12 cells. 
Discussion 
Effect of TRa4 on PC12 Cell Differentiation: 
Evidence for a NGF-independent, Permissive 
Function in Neuronal Differentiation 
In this study, we provide the first direct evidence that TRot-1 
controls neuronal differentiation a d expression of neuron- 
specific genes in PC12 cells. Both NGF-induced neuronal 
differentiation a d expression of late genes are arrested by 
TRtx-1 in the absence of its ligand, T3, while the block is 
released in the presence of the hormone, leading to efficient 
cell maturation (see Fig. 9 for a model). These effects of 
TRot-1 are strikingly similar to those observed in avian 
erythroblasts where TRot-1 regulates erythroid ifferentia- 
tion and erythrocyte gene expression in a T3-dependent 
fashion (Zenke et al., 1990; Disela et al., 1991). 
How does unliganded TRot-1 arrest neuronal differentia- 
tion? First, its action seems to be independent of NGF, since 
it did not affect expression of NGF-induced early genes. It 
also failed to inhibit NGF action completely since NGF- 
treated TRo~-I-PC12 cells formed short neurites and lost ex- 
pression of the early neuronal marker MASH-1. Rather, 
TRot-1 probably causes a late block in neuronal differentia- 
tion, perhaps by repressing or limiting the expression of in- 
dispensable, neuron-specific proteins. A possible candidate 
for such proteins is N-CAM, whose expression correlates 
very well with morphological differentiation f PC12 cells 
and causes neurite formation if expressed artificially in non- 
neuronal cells (Mann et al., 1989; Doherty et al., 1991). 
However, it is more likely that he observed block of differen- 
tiation is a combined result of the insufficient expression of 
many proteins with such diverse functions as maintenance of 
neurite structure or function and regulation of cell motility 
or cell-substrate adhesion. 
The second important effect of TRot-1 was its ability to ren- 
der differentiating PC12 cells dependent on NGF for sur- 
vival. These results may correspond to the well-known fact 
that primary neurons differentiating in culture require neuro- 
trophic factors for survival and neurite outgrowth. By such 
a mechanism, TRa-1 could control naturally occurring neu- 
ronal death during vertebrate development where large per- 
centages (up to 80%) of certain neuronal populations un- 
dergo programmed cell death (Oppenheim, 1991). In line 
with this idea, thyroid hormone controls tissue regression 
and neuronal death during amphibian metamorphosis 
(Kollros, 1981; Tata, 1984; Tata et al., 1991)and the survival 
of cerebellar granule cells in hypothyroid rats (Lewis et al., 
1976). 
The effects of TRo~-I and thyroid hormone were not limited 
to PC12 cells. Studies on the E 18 cell line suggest that simi- 
lar mechanisms are likely to be operating in vivo in selected 
neuronal populations of the CNS. In line with these findings 
we propose that TRo~-I controls neuronal differentiation i  
a permissive fashion: Neuronal progenitor ceils are arrested 
at a certain stage of maturation by nonliganded TRot-l, until 
they are released to differentiate when ligand becomes avail- 
able. At this stage, neurotrophic factors like NGF are re- 
quired for survival of the differentiating cells. Thus, locally 
produced neurotrophic factors (NGF) and the systemic en- 
docrine agent T3 seem to cooperate in optimal induction of 
neuronal differentiation and neuronal gene expression. 
Cooperation of thyroid hormone and NGF has been demon- 
strated in vivo during development of the hippocampus, ol- 
factory bulb, and cerebellum (Clos and Legrand, 1990), 
regions which express abundantly the TRo~-I isoform of T3 
receptor (MellstrSm et al., 1991). 
In contrast to the erythroblast ystem (Schroeder et al., 
1992a,b), TRa-1 does not seem to cooperate with RAPs in 
neuronal differentiation f PC12 cells since the respective 
ligand (RA) did not affect his process or its regulation by 
TRot-1. Whether such a cooperation would occur upon 
artificial expression of RAPs via retrovirus vectors or in mu- 
tant PC12 cells expressing elevated RAR levels (Scheibe t 
al., 1991) remains to be determined. The RAPs might, how- 
ever, be involved in regulating chromaffin differentiation, 
since RA induced morphological changes in PC12 cells 
resembling those induced by DEX. If this was true, the 
RAPs might antagonize the function of TRot-1 rather than 
cooperating with it. 
V-erbA Acts Like a Weak Constitutive Repressor of 
NGF-induced Differentiation and Gene Expression 
In contrast to TRo~-I, the v-erbA oncoprotein caused a par- 
tial, but constitutive block of NGF-induced PC12 cell 
differentiation. With the exception of the transin gene, ex- 
pression of which was constitutively repressed by v-erbA, 
NGF regulation of other late genes studied was hardly 
affected by v-erbA. This could be due to the fact that v-erbA 
has a lower binding affinity to regulatory sequences oftarget 
genes (Sap et al., 1989; Disela et al., 1991). In addition, its 
expression level in PC12 cells was perhaps not high enough 
to efficiently repress the genes studied other than transin. 
Even in avian erythroblasts (the cell type in which v-erbA 
has been selected for its oncogenic activity) a large excess 
ofv-erbA is necessary torepress genes activated by TRa-1/c- 
erbA or RAPS (Disela et al., 1991; Schroeder et al., 1992a). 
Our results uggest that v-erbA constitutively affects both 
lineages of PC12 cell differentiation. It partially arrests neu- 
ronal differentiation a d gene expression, and also inhibits 
chromaffin differentiation although it is able to constitutively 
turn on some DEX-induced genes. As a result, v-erbA gives 
rise to an aberrant "interlineage" phenotype characterized by
coexpression of certain neuronal and chromaffin markers 
(see Fig. 9 for a model). There are two nonexclusive possi- 
bilities to explain how v-erbA and TRt~-l/c-erbA affect 
chromaffin differentiation and gene expression in such a 
different fashion. First, the point mutations in the v-erbA 
DNA binding domain might alter the DNA binding 
specificity of this mutated hormone receptor in that it now 
constitutively activates genes that are repressed by TRot-I. 
More likely, however, v-erbA differs from TRa-1/c-erbA in
the way it interacts with other transcription factors uch as 
RAPs (Sharif and Privalsky, 1991, Desbois et al., 1991) or 
members of the AP-1 transcription factor family (Zhang et 
al., 1991) in transient transcription assays using standard cell 
lines. This functional difference between v-erbA and TRot-1 
may both explain their different regulation of the chromaffin 










Published April 15, 1993
marker gene tyrosine hydroxylase and their different effect 
on NGF-regulated proliferation of PC12 cells. Zhang et al. 
(1991) recently reported that T3-activated c-erbA inhibits 
AP-1 activity in transiently transfected cells. This may ex- 
plain why 1"3 inhibits cell proliferation in TRtx-I-PC12 
cells. In addition, these authors showed that a truncated 
c-erbA carrying a COOH-terminal deletion very similar to 
that present in v-erbA was unable to block AP-1 activity, per- 
haps explaining why proliferation of our v-erbA-PC12 cells 
was not affected by T3 (Fig. 4 A). 
TRa-l-dependent Regulation of PC12 Differentiation: 
Relevance for Neuronal Differentiation i the CNS 
Our results have several immediate consequences for the un- 
derstanding of how thyroid hormone might act in the CNS. 
The observed permissive action of TRc~-I on neuron matura- 
tion could be an underlying mechanism for the abnormalities 
occurring in the hypothyroid rat brain. Unliganded TRc~-I 
might cause a late block in neurotrophin-dependent euronal 
maturation. Similarly, the observation that the lesions can be 
reverted by T3 administration during a critical period 
(Legrand, 1984) agrees well with the fact that T3 releases 
the cells from this late block. By using the PC12 cell line ap- 
proach, we were able to identify a good-sized number of can- 
didate genes for regulation by T3 and its receptor. Such 
genes may be impossible to detect by eDNA library screen- 
ing approaches employing the whole brain or parts of it (Mu- 
fioz et al., 1991), since they may only occur in selected neu- 
ronal cell populations or during specific phases of brain 
development. 
Although this work strongly suggests a direct, important 
role of thyroid hormone receptors in brain development, we 
are ignorant about mechanisms governing TR expression, 
the ratios between the different TR types, and the (likely) 
functional differences between the different TRs. Thus, 
studies like those presented here will have to be extended to 
other, preferably brain-derived neural cell types, to other TR 
types, and to the other neurotrophic factors recently 
identified (Barde et al., 1982; Leibrock et al., 1989; Lin et 
al., 1989; Hohn et al., 1990; Jones and Reichardt, 1990; 
Maisonpierre et al., 1990; Berkemeier et al., 1991; Hall- 
b66k et al., 1991). An obvious choice for such systems will 
be neuroblast lines such as the E 18 line described here. Due 
to the instability of such lines and their reported ability to 
change their phenotype (e.g., from neuronal to glial, Gage, 
1992), more work is required before such lines can be used 
for molecular studies in the fashion described here for the 
PC12 system. 
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